5th Oligonucleotides Analytical Development & CMC Summit.

The 5th Oligonucleotides Analytical Development & CMC Summit is a leading industry event dedicated to advancing analytical development, chemistry, manufacturing and controls (CMC), quality, and regulatory strategies for oligonucleotide therapeutics. The summit brings together pharmaceutical and biotechnology professionals to discuss the latest innovations in analytical characterization, process development, manufacturing, quality control, and regulatory compliance for antisense oligonucleotides (ASOs), siRNA, gRNA, and other next-generation oligonucleotide therapies.

Through expert-led presentations, technical case studies, interactive discussions, and networking opportunities, attendees will gain practical insights into overcoming analytical and manufacturing challenges while accelerating the development and commercialization of safe, scalable, and regulatory-ready oligonucleotide therapeutics.